Be sure all employees are safe from COVID-19—now possible with the Salus mobile solution. This suite of mobile apps and testing methodology brings back collaboration and productivity to get back to a normal workplace while preventing the threat of coronavirus from further jeopardizing employment opportunities.
Typically, the investment in Salus includes the Rapid Assurance Antigen COVID-19 test, with the Salus app included as one all-in price. Salus, however, is tailored for every engagement and is customized to the needs of the property. Salus consultants will meet with stakeholders of the property to determine if Salus is a fit. Depending on the organization's requirements, a one-time, cost-effective set-up and configuration charge, and a small per-use fee for the app, and testing essentially as a pass-through to reduce investment.
We understand that with regards to Salus, "one size DOES NOT fit all." For example, with some sports organizations, we are having discussions about a "phased" approach, whereby phase one involves testing and providing Salus for employees, venue personnel, players, and a limited number of fans. For others, the organization wants to provide access for the entire venue and all fans, so we will work with the entity to create an implementation plan that accommodates that approach.
The Salus app is designed to be used by a variety of industries and sectors, including colleges and universities, workplaces, arenas, cruises, resorts and hotels, assisted care facilities, and so much more.
Frequency of testing depends on a number of factors. Typically, Salus consultants, in coordination with our medical advisory team, will make recommendations as to the appropriate testing frequency and overall protocol.
Dr. Stewart Davis is Salus’ Chief Medical Officer. Dr. Davis is an M.D. by training but has been a full-time medical device entrepreneur for the last 17+ years. He has founded or held an executive position in 12 medical device companies. Dr. Davis graduated from the University of Miami’s Miller School of Medicine and was Summa Cum Laude from the University of Miami Honors Program. He has published a book and over a dozen peer-reviewed papers.
Dr. Peter Antevy is the Medical Advisor to the Salus solution. Dr. Antevy earned his medical degree from the University of Miami’s School of Medicine and has acquired a subspecialty degree in Pediatric Emergency Medicine. He currently works as a Pediatric Emergency Medicine physician practicing in-hospital emergency medical care at Joe DiMaggio Children’s Hospital. He is a COVID-19 science and testing expert and is currently working with multiple US cities to define their protocols and run their testing programs. Dr. Antevy is heavily involved in COVID-19 research, and he is the Principle Investigator on two large antibody trials across seven municipalities in South Florida. Additionally, he is leading clinical trials on Rapid Assurance Antigen testing in multiple venues across the country.
Doug is responsible for working with the executive and business development team in bringing OZ's Salus solution to market. He leads OZ's business development efforts and is single-minded in finding ways to provide his clients with the right solutions to solve the challenges they face in dealing with the challenges associated with the COVID-19 pandemic.
He has 20+ years of experience advising companies in the technology, professional services, and manufacturing space on business development, customer experience, and leadership best practices. Doug is the company’s spokesperson, and key point of contact for COVID-19 test manufacturers, having developed relationships with multiple international providers.
Previously, Doug was one of the founders of a company in the litigation consulting space, which grew over 17 years from three employees to over 300, and was successfully sold to a 55,000 employee public company. He is a frequent national speaker on business development, communications, customer experience, and leadership best practices.